565 related articles for article (PubMed ID: 9622338)
1. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
[TBL] [Abstract][Full Text] [Related]
2. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
Riches FM; Watts GF; Hua J; Stewart GR; Naoumova RP; Barrett PH
J Clin Endocrinol Metab; 1999 Aug; 84(8):2854-61. PubMed ID: 10443691
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.
Riches FM; Watts GF; van Bockxmeer FM; Hua J; Song S; Humphries SE; Talmud PJ
J Lipid Res; 1998 Sep; 39(9):1752-8. PubMed ID: 9741687
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
[TBL] [Abstract][Full Text] [Related]
5. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity.
Watts GF; Riches FM; Humphries SE; Talmud PJ; van Bockxmeer FM
J Lipid Res; 2000 Mar; 41(3):481-8. PubMed ID: 10706596
[TBL] [Abstract][Full Text] [Related]
6. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
7. Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man.
Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
Atherosclerosis; 1997 Nov; 135(1):83-91. PubMed ID: 9395276
[TBL] [Abstract][Full Text] [Related]
8. Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
Watts GF; Chan DC; Barrett PH; Susekov AV; Hua J; Song S
Obes Res; 2003 Jan; 11(1):152-9. PubMed ID: 12529498
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue compartments and the kinetics of very-low-density lipoprotein apolipoprotein B-100 in non-obese men.
Watts GF; Chan DC; Barrett PH
Metabolism; 2002 Sep; 51(9):1206-10. PubMed ID: 12200768
[TBL] [Abstract][Full Text] [Related]
10. Determinants of the kinetics of very low-density lipoprotein apolipoprotein B-100 in non-obese men.
Watts GF; Riches FM; Kelly JM; Powell MA; Croft KD
Clin Exp Pharmacol Physiol; 1997 Aug; 24(8):556-62. PubMed ID: 9269527
[TBL] [Abstract][Full Text] [Related]
11. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study.
Cummings MH; Watts GF; Pal C; Umpleby M; Hennessy TR; Naoumova R; Sönksen PH
Clin Sci (Lond); 1995 Feb; 88(2):225-33. PubMed ID: 7720348
[TBL] [Abstract][Full Text] [Related]
12. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH
Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.
Watts GF; Naoumova RP; Kelly JM; Riches FM; Croft KD; Thompson GR
Am J Physiol; 1997 Sep; 273(3 Pt 1):E462-70. PubMed ID: 9316434
[TBL] [Abstract][Full Text] [Related]
14. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF
Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431
[TBL] [Abstract][Full Text] [Related]
15. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease.
Cummings MH; Watts GF
Clin Chem; 1995 Jan; 41(1):111-4. PubMed ID: 7813057
[TBL] [Abstract][Full Text] [Related]
16. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Naoumova R; Slavin BM; Thompson GR; Sönksen PH
Diabetologia; 1995 Aug; 38(8):959-67. PubMed ID: 7589883
[TBL] [Abstract][Full Text] [Related]
17. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study.
Christ ER; Cummings MH; Albany E; Umpleby AM; Lumb PJ; Wierzbicki AS; Naoumova RP; Boroujerdi MA; Sönksen PH; Russell-Jones DL
J Clin Endocrinol Metab; 1999 Jan; 84(1):307-16. PubMed ID: 9920100
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
19. Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
Chan DC; Watts GF; Barrett PH; Beilin LJ; Redgrave TG; Mori TA
Diabetes; 2002 Aug; 51(8):2377-86. PubMed ID: 12145148
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
